🚧 構築中 — データが不正確な場合があります。企業や指標を随時追加しています。
Boston Scientific Corporation logo

Boston Scientific Corporation

BSX順位 #213ヘルスケア医療機器

時価総額

$74.5B

世界順位

#213

過去最高値

$141.7B

2025-12-31

総成長率

+0%

2026年以降

Market Cap Context

  • Larger than 42% of the 367 companies we track (globally).
  • Equivalent to 0.2% of United States's GDP (2025 data).
  • Just above: #212 Airbnb, Inc. ($75.2B)
  • Just below: #214 Eni S.p.A. ($74.3B)
  • Best year: 1995 (+183%). Worst year: 2026 (-47%).

Boston Scientific Corporation Financial Breakdown (FY 2025)

Source: Yahoo Finance — BSX annual filings (2025)

$20.1B revenue · $4.0B operating income · $2.9B net income

  • Operating margin: 19.8% on $20.1B in revenue.
  • R&D is 10.2% of revenue ($2.1B).
  • Net income margin: 14.4% — $2.9B in profit.
  • Free cash flow: $3.4B (17.0% of revenue).

Cost / Operating Expenses

Total operating expenses $16.1B

Total

$15.2B

Cost of revenue· Product / service delivery costs (COGS)$6.2B41.0%
Research & development$2.1B13.5%
Selling, general & administrative· Sales, marketing, and corporate overhead$6.9B45.4%

Capital Expenditures

$1.1B

This fiscal year (near-total AI infrastructure buildout)

Free Cash Flow

$3.4B

Trailing twelve months

Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.

Boston Scientific Corporationについて

Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Boston Scientific Corporationの時価総額推移 (20262026)

Boston Scientific Corporation vs Sector Peers by Market Cap

SanofiSAN.PA
$99.2B
HCA Healthcare, Inc.HCA
$89.8B
Elevance Health, Inc.ELV
$84.6B
Regeneron Pharmaceuticals, Inc.REGN
$81.5B
Boston Scientific CorporationBSX
$74.5B
The Cigna GroupCI
$72.8B
Takeda Pharmaceutical Company Limited4502.T
$59.0B
Becton, Dickinson and CompanyBDX
$49.6B

Boston Scientific Corporationを比較

順位の推移

時価総額順位前年比
2026$74.5B#213(101)-47.4%
2025$141.7B#112(14)+6.8%
2024$132.8B#98(34)+54.5%
2023$85.9B#132(1)+24.9%
2022$68.8B#131(22)+8.9%
2021$63.1B#153(12)+18.2%
2020$53.4B#165(63)-20.5%
2019$67.2B#102(8)+28.0%
2018$52.5B#94(66)+42.6%
2017$36.8B#160(18)+14.6%
2016$32.1B#142(6)+17.3%
2015$27.4B#148(46)+39.2%
2014$19.7B#194(8)+10.2%
2013$17.9B#186(36)+109.8%
2012$8.5B#222(15)+7.3%
2011$7.9B#207(27)-29.5%
2010$11.3B#180(37)-15.9%
2009$13.4B#143(23)+16.3%
2008$11.5B#120(8)-33.4%
2007$17.3B#128(59)-32.3%
2006$25.5B#69(28)-29.8%
2005$36.4B#41(25)-31.1%
2004$52.8B#16(1)-3.3%
2003$54.6B#15(11)+72.9%
2002$31.6B#26(35)+76.3%
2001$17.9B#61(32)+76.2%
2000$10.2B#93(34)-37.4%
1999$16.3B#59(18)-18.4%
1998$19.9B#41(3)+16.9%
1997$17.0B#38(17)-23.5%
1996$22.3B#21(1)+21.8%
1995$18.3B#20(12)+183.5%
1994$6.5B#32

その他のヘルスケア企業

よくある質問

What is Boston Scientific Corporation's market cap?

Boston Scientific Corporation (BSX) has a market capitalization of $74.5B, making it the #213 largest company in the world by market cap.

What was Boston Scientific Corporation's highest market cap?

Boston Scientific Corporation's all-time high market cap was $141.7B, reached in 2025-12-31. Its highest rank was #112 in 2025.

What sector is Boston Scientific Corporation in?

Boston Scientific Corporation is in the Healthcare sector, specifically the Medical Devices industry. It is based in United States.

How has Boston Scientific Corporation's market cap changed over time?

Boston Scientific Corporation has been tracked since 2026. Its market cap has grown by 0% from $74.5B in 2026 to $74.5B today.